Dipna Pharmachem Receives Trading Approval for 22.44 Lakh Equity Shares

Dipna Pharmachem Ltd has received trading approval from BSE Limited for 22,44,000 fully paid-up equity shares. These shares are being issued at a premium of Rs. 3.05/- each to non-promoters on a preferential basis pursuant to the conversion of warrants. The approval was received in reference to the in-principle application submitted by the Company on 13 March 2025 for the issuance of Convertible Warrants on a preferential basis.